Business Description
Aeglea BioTherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00773J1034
Description
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare metabolic diseases. The company competes in the segments of the pharmaceutical, biotechnology and other related markets that address rare genetic diseases.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 54.34 | |||||
| Equity-to-Asset | -0.85 | |||||
| Debt-to-Equity | -0.02 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -7.39 | |||||
| Beneish M-Score | 11.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.6 | |||||
| 3-Year EPS without NRI Growth Rate | 26.1 | |||||
| 3-Year FCF Growth Rate | 23.2 | |||||
| 3-Year Book Growth Rate | -28 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.85 | |||||
| 9-Day RSI | 35.51 | |||||
| 14-Day RSI | 39.9 | |||||
| 6-1 Month Momentum % | 53.58 | |||||
| 12-1 Month Momentum % | 2.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.03 | |||||
| Quick Ratio | 1.03 | |||||
| Cash Ratio | 1.01 | |||||
| Days Sales Outstanding | 104.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31 | |||||
| Shareholder Yield % | 1.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -6961.16 | |||||
| Net Margin % | -22195.36 | |||||
| ROE % | -4815.53 | |||||
| ROA % | -241.03 | |||||
| ROIC % | -172.08 | |||||
| ROC (Joel Greenblatt) % | -1413.88 | |||||
| ROCE % | -156.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 43.3 | |||||
| EV-to-EBIT | 2.15 | |||||
| EV-to-EBITDA | 2.19 | |||||
| EV-to-Revenue | -149.85 | |||||
| EV-to-Forward-Revenue | 18.54 | |||||
| EV-to-FCF | 2.7 | |||||
| Earnings Yield (Greenblatt) % | 46.51 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AGLE
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aeglea BioTherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.228 | ||
| EPS (TTM) ($) | -71 | ||
| Beta | 2.94 | ||
| Volatility % | 284.08 | ||
| 14-Day RSI | 39.9 | ||
| 14-Day ATR ($) | 1.678407 | ||
| 20-Day SMA ($) | 13.657 | ||
| 12-1 Month Momentum % | 2.44 | ||
| 52-Week Range ($) | 2.66 - 39 | ||
| Shares Outstanding (Mil) | 4.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aeglea BioTherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aeglea BioTherapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aeglea BioTherapeutics Inc Frequently Asked Questions
What is Aeglea BioTherapeutics Inc(AGLE)'s stock price today?
The current price of AGLE is $12.35. The 52 week high of AGLE is $39.00 and 52 week low is $2.66.
When is next earnings date of Aeglea BioTherapeutics Inc(AGLE)?
The next earnings date of Aeglea BioTherapeutics Inc(AGLE) is 2023-11-03 Est..
Does Aeglea BioTherapeutics Inc(AGLE) pay dividends? If so, how much?
Aeglea BioTherapeutics Inc(AGLE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers